CFDE Data Portal | Search LINC02321

	Label	Description
	LINC02321 Gene (Entity type)	ENSG00000258884 - long intergenic non-protein coding RNA 2321
	GSE114883 romidepsin T cell 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE171692 FXN knockdown 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE230634 PARP inhibition 5 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE195568 palbociclib 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 5 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 7 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE230634 PARP inhibition 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE140758 MDM2 inhibition 0 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC02321

ENSG00000258884 - long intergenic non-protein coding RNA 2321

GSE114883 romidepsin T cell 1 v 4 human up

A Gene Set from LINCS

GSE171692 FXN knockdown 1 v 0 human up

A Gene Set from LINCS

GSE230634 PARP inhibition 5 v 4 human dn

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 0 v 3 human dn

A Gene Set from LINCS

GSE195568 palbociclib 2 v 4 human dn

A Gene Set from LINCS

GSE226249 pirfenidone HL 5 v 8 human dn

A Gene Set from LINCS

GSE261563 CX-5461 7 v 1 human dn

A Gene Set from LINCS

GSE230634 PARP inhibition 5 v 1 human dn

A Gene Set from LINCS

GSE140758 MDM2 inhibition 0 v 7 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.